Researchers Are Testing Whether Psilocybin Can Treat Depression in Lung Cancer Patients

Automatically curated summary from The Debrief.

Researchers at The Ohio State University Comprehensive Cancer Center are conducting a clinical trial testing psilocybin-assisted therapy for depression in non-small cell lung cancer patients. The experimental intervention involves eight hours of preparatory therapy, a single controlled psilocybin dose, and integrative counseling. Although one participant reported positive preliminary improvements, full trial results are not yet available. Researchers emphasize that psilocybin treatment remains experimental and unapproved by regulators for general clinical use, requiring careful participant screening and medical supervision.

Context and limitations

Trial results have not yet been published, individual patient claims are strictly anecdotal, and psilocybin-assisted therapy remains an experimental treatment that is not regulator-approved for general clinical use.